Lennart Åström

The HOPE (Heart Outcomes Prevention Evaluation) Study: The design of a large, simple randomized trial of an angiotensin converting enzyme inhibitor (ramipril) and vitamin E in patients at high risk of cardiovascular events

F Mindlen, Roberto Nordaby, M I Soto Ruiz et al. · Queensland's institutional digital repository (The University of Queensland) · 1996 · 154 citations

Medicine, Cardiology, Pharmacotherapy +17

Long-term outcome of high dose rate brachytherapy in radiotherapy of localised prostate cancer

Lennart Åström, Dorte Pedersen, Claes Mercke et al. · Radiotherapy and Oncology · 2004 · 134 citations

Medicine, Radiation Oncology, Urology +16

Continuous enzalutamide after progression of metastatic castration-resistant prostate cancer treated with docetaxel (PRESIDE): an international, randomised, phase 3b study

Axel S. Merseburger, Gerhardt Attard, Lennart Åström et al. · The Lancet Oncology · 2022 · 39 citations

Medicine, Oncology, Pharmacology +14

Hypofractionated Proton Boost Combined with External Beam Radiotherapy for Treatment of Localized Prostate Cancer

Silvia Johansson, Lennart Åström, Fredrik Sandin et al. · Prostate Cancer · 2012 · 37 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Docetaxel Versus Surveillance After Radical Radiotherapy for Intermediate- or High-risk Prostate Cancer—Results from the Prospective, Randomised, Open-label Phase III SPCG-13 Trial

Pirkko‐Liisa Kellokumpu‐Lehtinen, Marie Hjälm-Eriksson, Camilla Thellenberg‐Karlsson et al. · European Urology · 2019 · 34 citations · Full text

Medicine, Oncology, Urology +15